Invir.IO – Transgene

Transgene and BioInvent present preclinical data demonstrating BT-001’s powerful activity against solid tumors

20200515 BT-001_AACR curtain raiser EN

By nh|2020-05-14T17:41:23+02:00May 15th, 2020|BT-001, Invir.IO, Press release|Comments Off

20191211 PR preclinical BT001 EN

By nh|2020-02-13T16:10:40+01:00December 11th, 2019|BT-001, Invir.IO, Press release|Comments Off

Transgene SITC 2019 Poster Jean-Baptiste Marchand et al. SITC 2019 [...]

By Lucie Larguier|2019-11-12T11:38:15+01:00November 6th, 2019|Invir.IO, Publication|Comments Off

20190502 - TG-AZ agreement - ENG

By alcyon|2019-06-03T19:41:55+02:00May 2nd, 2019|Invir.IO, Press release|Comments Off

20190326 PR BioInvent extension CDR US

By Lucie Larguier|2019-06-03T19:41:50+02:00March 26th, 2019|Invir.IO, Press release|Comments Off

Jean-Baptiste Marchand et al. SITC 2018, November 2018 - Abstract [...]

By alcyon|2019-07-01T16:03:15+02:00November 7th, 2018|Invir.IO, Publication|Comments Off

20181107 SITC Poster EN

By alcyon|2020-04-03T08:29:57+02:00November 7th, 2018|Invir.IO, Myvac, Press release|Comments Off

20181107 SITC Joint BioInvent Transgene EN

By alcyon|2019-06-03T19:40:34+02:00November 7th, 2018|Invir.IO, Press release|Comments Off

20181001 SITC Poster VEN

By alcyon|2019-06-03T19:46:22+02:00October 2nd, 2018|Invir.IO, Myvac, Press release|Comments Off

BioInvent and Transgene collaborate on next generation oncolytic viruses encoding [...]

By alcyon|2019-06-03T19:51:59+02:00December 6th, 2017|Invir.IO, Press release|Comments Off